Unknown

Dataset Information

0

A remote arene-binding site on prostate specific membrane antigen revealed by antibody-recruiting small molecules.


ABSTRACT: Prostate specific membrane antigen (PSMA) is a membrane-bound glutamate carboxypeptidase overexpressed in many forms of prostate cancer. Our laboratory has recently disclosed a class of small molecules, called ARM-Ps (antibody-recruiting molecule targeting prostate cancer) that are capable of enhancing antibody-mediated immune recognition of prostate cancer cells. Interestingly, during the course of these studies, we found ARM-Ps to exhibit extraordinarily high potencies toward PSMA, compared to previously reported inhibitors. Here, we report in-depth biochemical, crystallographic, and computational investigations which elucidate the origin of the observed affinity enhancement. These studies reveal a previously unreported arene-binding site on PSMA, which we believe participates in an aromatic stacking interaction with ARMs. Although this site is composed of only a few amino acid residues, it drastically enhances small molecule binding affinity. These results provide critical insights into the design of PSMA-targeted small molecules for prostate cancer diagnosis and treatment; more broadly, the presence of similar arene-binding sites throughout the proteome could prove widely enabling in the optimization of small molecule-protein interactions.

SUBMITTER: Zhang AX 

PROVIDER: S-EPMC2965167 | biostudies-literature | 2010 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

A remote arene-binding site on prostate specific membrane antigen revealed by antibody-recruiting small molecules.

Zhang Andrew X AX   Murelli Ryan P RP   Barinka Cyril C   Michel Julien J   Cocleaza Alexandra A   Jorgensen William L WL   Lubkowski Jacek J   Spiegel David A DA  

Journal of the American Chemical Society 20100901 36


Prostate specific membrane antigen (PSMA) is a membrane-bound glutamate carboxypeptidase overexpressed in many forms of prostate cancer. Our laboratory has recently disclosed a class of small molecules, called ARM-Ps (antibody-recruiting molecule targeting prostate cancer) that are capable of enhancing antibody-mediated immune recognition of prostate cancer cells. Interestingly, during the course of these studies, we found ARM-Ps to exhibit extraordinarily high potencies toward PSMA, compared to  ...[more]

Similar Datasets

| S-EPMC2794306 | biostudies-literature
| S-EPMC5581714 | biostudies-literature
| S-EPMC5995913 | biostudies-literature
| S-EPMC7105266 | biostudies-literature
| S-EPMC6484861 | biostudies-literature
| S-EPMC5508854 | biostudies-other
| S-EPMC8157400 | biostudies-literature
| S-EPMC4217211 | biostudies-literature
| S-EPMC3145341 | biostudies-literature
| S-EPMC7957835 | biostudies-literature